Cargando…
Inhibitor of Apoptosis Protein-Like Protein-2 as a Novel Serological Biomarker for Breast Cancer
Inhibitor of apoptosis protein-like protein-2 (ILP-2) has only been detected in the testis and in lymphoblastoid cells. Although previous studies have not reported the presence of ILP-2 in breast cancer tissues, this study indicates the presence of ILP-2 in breast cancer serum samples. To validate w...
Autores principales: | Xiang, Mingjun, Zhou, Wei, Gao, Dandan, Fang, Xiansong, Liu, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546717/ https://www.ncbi.nlm.nih.gov/pubmed/23222679 http://dx.doi.org/10.3390/ijms131216737 |
Ejemplares similares
-
Inhibitor of apoptosis protein-like protein-2: A novel growth accelerator for breast cancer cells
por: Zhu, Lin, et al.
Publicado: (2018) -
Proteomic analysis of inhibitor of apoptosis protein-like protein-2 on breast cancer cell proliferation
por: Xiang, Siqi, et al.
Publicado: (2022) -
Inhibitor of apoptosis proteins in breast cancer
por: Foster, FM, et al.
Publicado: (2006) -
Autoantibodies against insulin-like growth factor-binding protein-2 as a serological biomarker in the diagnosis of lung cancer
por: ZHANG, YING, et al.
Publicado: (2012) -
Inhibitor of apoptosis proteins as a therapeutic target in breast cancer
por: Foster, FM, et al.
Publicado: (2008)